2022
DOI: 10.1016/j.chom.2021.11.001
|View full text |Cite
|
Sign up to set email alerts
|

Human gut bacterial metabolism drives Th17 activation and colitis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

5
90
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 103 publications
(95 citation statements)
references
References 75 publications
5
90
0
Order By: Relevance
“…IL-17 has been shown to promote the development of colon cancer 37. Previous study showed that E. lenta was enriched in patients with IBD and it could induce IL-17a, by the cardiac glycoside reductase 2 enzyme,38 supporting our finding that E. lenta may activate the proinflammatory cytokine IL-17 pathways to induce tumourigenesis. Activation of TNF-α pathway induces colitis and colorectal carcinogenesis 39.…”
Section: Discussionsupporting
confidence: 91%
“…IL-17 has been shown to promote the development of colon cancer 37. Previous study showed that E. lenta was enriched in patients with IBD and it could induce IL-17a, by the cardiac glycoside reductase 2 enzyme,38 supporting our finding that E. lenta may activate the proinflammatory cytokine IL-17 pathways to induce tumourigenesis. Activation of TNF-α pathway induces colitis and colorectal carcinogenesis 39.…”
Section: Discussionsupporting
confidence: 91%
“…Eggerthella lenta also possesses 3α- and one 3β-HSDH for converting DCA to isoDCA to reduce gut bacteria toxicity [ 56 ]. These HSDHs also convert LCA to 3-exoLCA and isoLCA, both of which modulate Th17 populations in mice [ 57 , 58 ].…”
Section: Ba Biosynthesismentioning
confidence: 99%
“…Gut microbiota is one of the major components of the intestinal mucosal barrier (13,14). A large body of evidence suggests that changes in the composition and function of gut microbes are key factors directly contributing to the onset and progression of IBD (15), and therefore targeting the gut microbiota may be a novel strategy for the treatment of IBD.…”
Section: Introductionmentioning
confidence: 99%